Fort Myers, Fla., Aug. 18, 2020 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute (FCS) welcomes medical oncologist and hematologist Kristen Gonter-Aubin, DO. She is seeing patients at the FCS Englewood office at 714 Doctors Drive, Englewood, FL and at the FCS Venice Healthpark location at 836 Sunset Lake Blvd, Suite 101, Venice, FL.
After earning her medical degree from Nova Southeastern College of Osteopathic Medicine in Ft. Lauderdale, FL, Kristen Gonter-Aubin, DO completed her residency in internal medicine at the University of Louisville. While there, she was appointed chief resident and participated in the Internal Medicine Steering Committee as vice chair. She was then awarded a fellowship in hematology/oncology from Moffitt Cancer Center through the University of South Florida, where she was named chief fellow.
Prior to joining FCS, Dr. Gonter-Aubin held various roles at the University of South Florida, where she served as a member of the Hematology/Oncology Fellow Committee, the Program Evaluation Committee and the Resident Advisory Committee. She has presented at conferences including the Moffitt Clinical Symposium and the American Society of Hematology (ASH) Annual Meeting, where her abstract was published in Blood.
“We’re excited to welcome Dr. Gonter-Aubin to FCS. She will undoubtedly be a tremendous addition to the Venice and Englewood communities and to our patients,” said FCS CEO Nathan Walcker.
FCS President & Managing Physician Dr. Lucio Gordan said, “Dr. Gonter-Aubin comes to us with outstanding clinical leadership skills, as demonstrated through her educational and professional careers. I am delighted to welcome her to FCS.”
###
About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. In the past four years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Trained in prestigious medical schools and research institutes, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.
Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy. Our highest values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians and staff.
*Prior to approval
Attachment